Chembio Asset Turnover Trend from 2010 to 2022

CEMI -  USA Stock  

USD 0.65  0.03  4.41%

Chembio Diagnostics Asset Turnover is decreasing over the last several years with slightly volatile swings. Asset Turnover is estimated to finish at 0.84 this year. During the period from 2010 to 2022 Chembio Diagnostics Asset Turnover regressed destribution of quarterly values had coefficient of variationof 37.34 and r-value of (0.89). Chembio Diagnostics Operating Expenses is most likely to increase significantly in the upcoming years. The last year's value of Operating Expenses was reported at 44.38 Million. The current Selling General and Administrative Expense is estimated to increase to about 26.8 M, while Consolidated Income is projected to decrease to (34.8 M).
  
Refresh
Check Chembio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chembio main balance sheet or income statement drivers, such as Direct Expenses of 37.2 M, Cost of Revenue of 28.6 M or Gross Profit of 13.3 M, as well as many exotic indicators such as Interest Coverage of 890, Long Term Debt to Equity of 0.56 or Calculated Tax Rate of 46.46. Chembio financial statements analysis is a perfect complement when working with Chembio Diagnostics Valuation or Volatility modules. It can also supplement various Chembio Diagnostics Technical models. Continue to the analysis of Chembio Diagnostics Correlation against competitors.

Chembio Asset Turnover Breakdown

Showing smoothed Asset Turnover of Chembio Diagnostics with missing and latest data points interpolated. Asset turnover is a measure of a firms operating efficiency; calculated by dividing Revenues by Average Assets. Often a component of DuPont ROE analysis.Chembio Diagnostics' Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chembio Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Asset Turnover10 Years Trend
Decreasing
Slightly volatile
 Asset Turnover 
Share
      Timeline 

Chembio Asset Turnover Regression Statistics

Arithmetic Mean 1.14
Geometric Mean 1.07
Coefficient Of Variation 37.34
Mean Deviation 0.33
Median 1.09
Standard Deviation 0.43
Sample Variance 0.18
Range 1.37
R-Value(0.89)
Mean Square Error 0.039974
R-Squared 0.80
Significance 0.00003929
Slope(0.1)
Total Sum of Squares 2.17

Chembio Asset Turnover History

2012 1.54
2013 1.32
2014 1.15
2015 1.06
2016 0.94
2017 1.26
2018 1.09
2019 0.69
2020 0.49
2021 0.72
2022 0.84

About Chembio Diagnostics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Chembio Diagnostics income statement, its balance sheet, and the statement of cash flows. Chembio Diagnostics investors use historical funamental indicators, such as Chembio Diagnostics's Asset Turnover, to determine how well the company is positioned to perform in the future. Although Chembio Diagnostics investors may use each financial statement separately, they are all related. The changes in Chembio Diagnostics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chembio Diagnostics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Chembio Diagnostics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Chembio Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Asset Turnover 0.72  0.84 
Average Assets66.1 M53.1 M
Tangible Asset Value70.2 M75.8 M
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or diagnose diseases. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York. Chembio Diagnostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 337 people.

Chembio Diagnostics Investors Sentiment

The influence of Chembio Diagnostics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chembio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Chembio Diagnostics Implied Volatility

    
  0.0  
Chembio Diagnostics' implied volatility exposes the market's sentiment of Chembio Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chembio Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chembio Diagnostics stock will not fluctuate a lot when Chembio Diagnostics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chembio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chembio Diagnostics' short interest history, or implied volatility extrapolated from Chembio Diagnostics options trading.

Current Sentiment - CEMI

Chembio Diagnostics Investor Sentiment

Most of Macroaxis users are currently bullish on Chembio Diagnostics. What is your opinion about investing in Chembio Diagnostics? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Chembio Diagnostics Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to the analysis of Chembio Diagnostics Correlation against competitors. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
20.4 M
Quarterly Revenue Growth YOY
1.16
Return On Assets
-0.26
Return On Equity
-1.53
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.